A mobile app as support for pelvic floor muscle training started prior to radical prostatectomy.
mobile application
pelvic floor muscle training
radical prostatectomy
self‐management
urinary incontinence
Journal
BJUI compass
ISSN: 2688-4526
Titre abrégé: BJUI Compass
Pays: United States
ID NLM: 101764975
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
16
08
2021
revised:
20
01
2022
accepted:
30
01
2022
entrez:
26
12
2022
pubmed:
27
12
2022
medline:
27
12
2022
Statut:
epublish
Résumé
To evaluate the usefulness of a mobile app to support pelvic floor muscle training (PFMT) started prior to radical prostatectomy (RP). A prospective cohort study conducted in Sweden from June 2018 to February 2021 including men for whom RP was planned within 12 months. Users responded anonymously to questionnaires at baseline, 1 and 3 months. Our primary aim was to evaluate if the app could facilitate PFMT and increase confidence in performing pelvic floor muscle (PFM) contractions correctly. Our second aim was to describe the change in urinary incontinence (UI) after RP, based on the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF). Of the 3043 users at baseline, 388 met the primary inclusion criteria. Of those, 71 (18.3%) were incontinent, predominantly with slight symptoms. The most common type was urge UI, 39/71 (54.9%). Of the 388 users, 159 (41.0%) answered the questionnaire at 1 month, and 131 (33.7%) at 3 months within 89-135 days. Of those 131, 127 (96.9%) indicated that the app facilitated their training 'a lot' or 'somewhat'. Confidence in performing PFM contractions correctly increased from 39.7% at baseline to 74.0% at 1 month and 87.8% at 3 months ( The mobile app facilitated pelvic floor muscle training for men who were planned to undergo radical prostatectomy and used the app.
Identifiants
pubmed: 36569504
doi: 10.1002/bco2.142
pii: BCO2142
pmc: PMC9766858
doi:
Types de publication
Journal Article
Langues
eng
Pagination
114-122Informations de copyright
© 2022 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.
Déclaration de conflit d'intérêts
The logos Tät and Tät.nu are registered as trademarks by the Swedish Patent and Registration office for eContinence AB, a Swedish e‐health company founded in July 2021 with the aim of maintaining, distributing, commercialising and further developing the apps created within the research project Tät.nu (eContinence.se). Eva Samuelsson is a co‐founder and shareholder of eContinence AB and the Managing Director. None of the other authors declare any conflict of interest.
Références
J Urol. 2015 Apr;193(4):1292-7
pubmed: 25308623
BMJ Open. 2021 Jan 4;11(1):e040819
pubmed: 33397664
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur Urol. 2016 Mar;69(3):460-7
pubmed: 26610857
J Med Internet Res. 2015 Feb 24;17(2):e52
pubmed: 25803266
Acta Obstet Gynecol Scand. 2013 Aug;92(8):909-15
pubmed: 23672520
Phys Ther. 2013 Jun;93(6):757-73
pubmed: 23431210
Neurourol Urodyn. 2009;28(5):411-5
pubmed: 19214996
Int Urogynecol J. 2010 Jul;21(7):835-40
pubmed: 20179901
Clin Interv Aging. 2019 Nov 12;14:1997-2005
pubmed: 31814714
Neurourol Urodyn. 2017 Jun;36(5):1369-1376
pubmed: 27611958
J Med Internet Res. 2019 Mar 14;21(3):e11296
pubmed: 30869644
Int Urogynecol J Pelvic Floor Dysfunct. 2009 Dec;20(12):1455-62
pubmed: 19690792
Urology. 2008 Dec;72(6):1280-6
pubmed: 18384853
BJU Int. 2021 May;127(5):575-584
pubmed: 32929874
Eur Urol. 2020 Dec;78(6):786-811
pubmed: 32616405
Neurourol Urodyn. 2004;23(4):322-30
pubmed: 15227649
Neurourol Urodyn. 2007;26(6):836-41
pubmed: 17330896
Transl Androl Urol. 2020 Oct;9(5):2146-2156
pubmed: 33209678
Female Pelvic Med Reconstr Surg. 2013 Jan-Feb;19(1):8-12
pubmed: 23321652
Nat Rev Urol. 2021 May;18(5):259-281
pubmed: 33833445
Eur J Phys Rehabil Med. 2012 Dec;48(4):689-705
pubmed: 23183454
Neurourol Urodyn. 2015 Sep;34(7):600-5
pubmed: 25998603
Neurourol Urodyn. 2020 Feb;39(2):533-546
pubmed: 31977112